728
Views
16
CrossRef citations to date
0
Altmetric
Review

Evidence of Antibiotic Resistance from Population-Based Studies: A Narrative Review

, , , , &
Pages 849-858 | Published online: 03 Mar 2021

References

  • Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51. doi:10.1038/nrmicro338025435309
  • Li B, Webster TJ. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res. 2018;36(1):22–32. doi:10.1002/jor.2365628722231
  • Giedraitienė A, Vitkauskienė A, Naginienė R, Pavilonis A. Antibiotic resistance mechanisms of clinically important bacteria. Medicina. 2011;47(3):19. doi:10.3390/medicina4703001921681007
  • Gajdács M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24(5):892.
  • Monserrat-Martinez A, Gambin Y, Sierecki E. Thinking outside the bug: molecular targets and strategies to overcome antibiotic resistance. Int J Mol Sci. 2019;20(6).
  • chaired by Jim O’Neill. Review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations [Internet]; 2019. Available from: https://amr-review.org/Publications.html. Accessed 215, 2021
  • Gajdács M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics. 2019;8(3):129.
  • WHO. WHO | Global action plan on AMR [Internet]; 2019. Available from: http://www.who.int/antimicrobial-resistance/global-action-plan/en/. Accessed 215, 2021.
  • Cycoń M, Mrozik A, Piotrowska-Seget Z. Antibiotics in the soil environment—degradation and their impact on microbial activity and diversity. Front Microbiol. 2019;10.
  • Felis E, Kalka J, Sochacki A, et al. Antimicrobial pharmaceuticals in the aquatic environment - occurrence and environmental implications. Eur J Pharmacol. 2020;866:172813. doi:10.1016/j.ejphar.2019.17281331751574
  • Mulvey MR, Simor AE. Antimicrobial resistance in hospitals: how concerned should we be? CMAJ. 2009;180(4):408–415. doi:10.1503/cmaj.08023919221354
  • van Duin D, Paterson D. Multidrug resistant bacteria in the community: trends and lessons learned. Infect Dis Clin North Am. 2016;30(2):377–390. doi:10.1016/j.idc.2016.02.00427208764
  • Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: a guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017;33(3):300–305. doi:10.4103/joacp.JOACP_349_1529109626
  • Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi:10.1016/S1473-3099(18)30605-430409683
  • de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 2016;13(11):e1002184. doi:10.1371/journal.pmed.100218427898664
  • Wernli D, Jørgensen PS, Harbarth S, et al. Antimicrobial resistance: the complex challenge of measurement to inform policy and the public. PLoS Med. 2017;14(8):e1002378. doi:10.1371/journal.pmed.100237828817562
  • Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7:58. doi:10.1186/s13756-018-0336-y29713465
  • Haddadin RN, Alsous M, Wazaify M, Tahaineh L. Evaluation of antibiotic dispensing practice in community pharmacies in Jordan: a cross sectional study. PLoS One. 2019;14(4):e0216115. doi:10.1371/journal.pone.021611531034528
  • Ventola CL. The antibiotic resistance crisis. Pharm Therap. 2015;40(4):277–283.
  • Rather IA, Kim B-C, Bajpai VK, Park Y-H. Self-medication and antibiotic resistance: crisis, current challenges, and prevention. Saudi J Biol Sci. 2017;24(4):808–812. doi:10.1016/j.sjbs.2017.01.00428490950
  • Davey P, Pagliari C, Hayes A. The patient’s role in the spread and control of bacterial resistance to antibiotics. Clin Microbiol Infect. 2002;8:43–68. doi:10.1046/j.1469-0691.8.s.2.6.x12427207
  • Liu J. Tackling the global non-prescription use of antibiotics. Lancet Infect Dis. 2020;20(2):169–170. doi:10.1016/S1473-3099(19)30744-332006505
  • Wogayehu B, Adinew A, Asfaw M. Knowledge on dispensed medications and its determinants among patients attending outpatient pharmacy at Chencha Primary Level Hospital, Southwest Ethiopia. Integr Pharm Res Pract. 2020;9:161–173. doi:10.2147/IPRP.S27440633117663
  • Simon B, Kazaura M. Prevalence and factors associated with parents self-medicating under-fives with antibiotics in Bagamoyo District Council, Tanzania: a cross-sectional study. Patient Prefer Adherence. 2020;14:1445–1453. doi:10.2147/PPA.S26351732884246
  • Gajdács M, Paulik E, Szabó A. Knowledge, attitude and practice of community pharmacists regarding antibiotic use and infectious diseases: a cross-sectional survey in Hungary (KAPPhA-HU). Antibiotics. 2020;9(2):41. doi:10.3390/antibiotics9020041
  • Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern Med. 2014;174(12):1914–1920.25285394
  • Bianco A, Papadopoli R, Mascaro V, Pileggi C, Pavia M. Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners. Infect Drug Resist. 2018;11:2199–2205. doi:10.2147/IDR.S17034930519057
  • Gurwitz JH. The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentum. Am J Med. 2012;125(6):523–524. doi:10.1016/j.amjmed.2012.02.00722513193
  • May L, Gudger G, Armstrong P, et al. Multisite exploration of clinical decision-making for antibiotic use by emergency medicine providers using quantitative and qualitative methods. Infect Control Hosp Epidemiol. 2014;35(9):1114–1125. doi:10.1086/67763725111919
  • Redberg RF. The problem of polypharmacy for nursing home residents comment on “prolonged antibiotic treatment in long-term care: role of the prescriber”. JAMA Intern Med. 2013;173(8):683.
  • Elias C, Moja L, Mertz D, Loeb M, Forte G, Magrini N. Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open. 2017;7:e016264.
  • Miller D. Update on the epidemiology and antibiotic resistance of ocular infections. Middle East Afr J Ophthalmol. 2017;24(1):30–42.28546690
  • Grosso A, Scarpa G, Romano M, et al. Choosing wisely: antibiotic use in ophthalmic surgery. Retina Today. 2019;48–53.
  • Steels S, van Staa TP. The role of real-world data in the development of treatment guidelines: a case study on guideline developers’ opinions about using observational data on antibiotic prescribing in primary care. BMC Health Serv Res. 2019;19(1):942.31805940
  • Smieszek T, Pouwels KB, Dolk FCK, et al. Potential for reducing inappropriate antibiotic prescribing in English primary care. J Antimicrob Chemother. 2018;73(suppl_2):ii36–43.29490058
  • Ciofi Degli Atti ML, D’Amore C, Ceradini J, et al. Prevalence of antibiotic use in a tertiary care hospital in Italy, 2008–2016. Ital J Pediatr. 2019;45(1):63.31109362
  • Löffler C, Krüger A, Daubmann A, et al. Optimizing antibiotic prescribing for acute respiratory tract infection in German primary care: study protocol for evaluation of the RESIST program. JMIR Res Protoc. 2020;9(9):e18648.32996888
  • Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large united states managed care network. Ophthalmology. 2017;124(8):1099–1107.28624168
  • Padget M, Guillemot D, Delarocque-Astagneau E. Measuring antibiotic consumption in low-income countries: a systematic review and integrative approach. Int J Antimicrob Agents. 2016;48(1):27–32.27318624
  • Aslam A, Gajdács M, Zin CS, Binti Abd Rahman NS, Ahmed SI, Jamshed SQ. Public awareness and practices towards self-medication with antibiotics among the Malaysian population. A development of questionnaire and pilot-testing. Antibiotics. 2020;9(2):97.
  • Lexi-Comp I. Lexicomp Drug Information Handbook. Wolters Kluwer: American Pharmaceutical Association; 2019.
  • Awad AI, Aboud EA. Knowledge, attitude and practice towards antibiotic use among the public in Kuwait. PLoS One. 2015;10(2):e0117910.25675405
  • Mengesha Y, Manaye B, Moges G. Assessment of public awareness, attitude, and practice regarding antibiotic resistance in Kemissie Town, Northeast Ethiopia: community-based cross-sectional study. Infect Drug Resist. 2020;13:3783–3789.33144831
  • Napolitano F, Izzo MT, Giuseppe GD, Angelillo IF. Public knowledge, attitudes, and experience regarding the use of antibiotics in Italy. PLoS One. 2013;8(12):e84177.24376793
  • Aslam A, Gajdács M, Zin CS, et al. Evidence of the practice of self-medication with antibiotics among the lay public in low- and middle-income countries: a scoping review. Antibiotics. 2020;9(9):597.
  • Wald-Dickler N, Spellberg B. Short-course antibiotic therapy—replacing constantine units with “shorter is better”. Clin Infect Dis. 2019;69(9):1476–1479.30615129
  • Wilson HL, Daveson K, Del Mar CB. Optimal antimicrobial duration for common bacterial infections. Aust Prescr. 2019;42(1):5–9.30765902
  • Dawson-Hahn EE, Mickan S, Onakpoya I, et al. Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews. Fam Pract. 2017;34(5):511–519.28486675
  • Allegranzi B, Zayed B, Bischoff P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e288–303.27816414
  • Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283.23327981
  • Daneman N, Gruneir A, Newman A, et al. Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011;66(12):2856–2863.21954456
  • Daneman N, Gruneir A, Bronskill SE, et al. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med. 2013;173(8):673.23552741
  • Daniel Markley J, Bernard S, Bearman G, Stevens MP. De-escalating antibiotic use in the inpatient setting: strategies, controversies, and challenges. Curr Infect Dis Rep. 2017;19(4):17.28365884
  • Tabah A, Bassetti M, Kollef MH, et al. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med. 2020;46(2):245–265.31781835
  • Masterton RG. Antibiotic De-Escalation. Crit Care Clin. 2011;27(1):149–162.21144991
  • Han H-S, Park DJ. Antibiotic prophylaxis and surgical site infection prevention. In: Ljungqvist O, Francis NK, Urman RD, editors. Enhanced Recovery After Surgery: A Complete Guide to Optimizing Outcomes [Internet]. Cham: Springer International Publishing; 2020:259–267.
  • Eliopoulos GM, Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36(11):1433–1437.12766839
  • Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–422.26706614
  • Atif M, Asghar S, Mushtaq I, et al. What drives inappropriate use of antibiotics? A mixed methods study from Bahawalpur, Pakistan. IDR. 2019;12:687–699.
  • Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect. 2013;66(5):401–414.23142195
  • Ryan J, McLornan L, O’Neill E. The impact of increasing antimicrobial resistance in the treatment of urosepsis. Ir J Med Sci. 2019.
  • Huang Y-WY, Alleyne A, Leung V, Chapman M. Urosepsis due to extended-spectrum β-lactamase–producing Escherichia coli: a retrospective, single-centre review of risk factors and clinical outcomes. Can J Hosp Pharm. 2018;71(2):119–127.29736045
  • Silva ACB, Anchieta LM, Lopes de P, Romanelli de C. Inadequate use of antibiotics and increase in neonatal sepsis caused by resistant bacteria related to health care assistance: a systematic review. Braz J Infect Dis. 2018;22(4):328–337.30125532
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.18625687
  • Munier A-L, Biard L, Legrand M, et al. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit. Int J Infect Dis. 2019;79:179–184.30529108
  • Bartoletti M, Giannella M, Lewis R, et al. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. Clin Microbiol Infect. 2018;24(5):546.e1–546.e8.
  • Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20(10):973–980.25273968
  • Tillotson GS, Zinner SH. Burden of antimicrobial resistance in an era of decreasing susceptibility. Expert Rev Anti Infect Ther. 2017;15(7):663–676.28580804
  • Leal JR, Conly J, Henderson EA, Manns BJ. How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations. Antimicrob Resist Infect Control. 2017;6(1):53.28588766
  • Shrestha P, Cooper BS, Coast J, et al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control. 2018;7:98.30116525
  • Anderson M, Clift C, Schulze K, et al. Averting the AMR crisis: what are the avenues for policy action for countries in Europe? [Internet]. European observatory on health systems and policies; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK543412/. Accessed 215, 2021.
  • Huebner C, Flessa S, Huebner N-O. The economic impact of antimicrobial stewardship programmes in hospitals: a systematic literature review. J Hosp Infect. 2019;102(4):369–376.30880265
  • Birgand G, Castro-Sánchez E, Hansen S, et al. Comparison of governance approaches for the control of antimicrobial resistance: analysis of three European countries. Antimicrob Resist Infect Control. 2018;7(1):28.29468055
  • Singh PK. One Health approach to tackle antimicrobial resistance in South East Asia. BMJ. 2017;358:j3625.28874363
  • Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA. 2017;318(7):607–608.28759678